Cg Oncology, Inc. · NASDAQ:CGON
Xiangmin Cui reported a 8.40% stake in Cg Oncology, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Xiangmin Cui reported a 8.40% stake in Cg Oncology, Inc., 6,371,669 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 8.40%
- Shares
- 6,371,669
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 7.00% | 5,315,954 |
| Decheng Capital Management IV (Cayman), LLC | 7.00% | 5,315,954 |
| Decheng Capital Global Healthcare Fund (Master), LP | 1.40% | 1,055,715 |
| Decheng Capital Global Healthcare GP, LLC | 1.40% | 1,055,715 |
| Xiangmin Cui | 8.40% | 6,371,669 |
Source
Related
- Cg Oncology, Inc.
- Decheng Capital Global Life Sciences Fund IV, L.P.
- Cg Oncology, Inc. shareholders
- Form 4 · Post Leonard E · Oct 19, 2026
- Form 4 · Post Leonard E · Sep 17, 2026
- Form 4 · Post Leonard E · Aug 18, 2026
- Schedule 13G/A · Foresite Capital Fund V, L.P. · Aug 14, 2026
- Schedule 13G/A · Rtw Investments, LP · Aug 14, 2026